A Canadian Study toward Changing Local Practice in the Diagnosis of Pediatric Celiac Disease

Table 2

Permeability results.

		All celiac patients	Serological diagnosis; ()	Biopsy diagnosis; ()	Control; ()
Baseline	L : M	0.043; (0.011–0.29)	0.049; (0.022–0.292)	0.034; (0.011–0.155)	0.022; (0.010–0.072)
	% FES	0.087; (0.003–0.448)	0.086; (0.011–0.448)	0.092; (0.003–0.27)	0.045; (0.010–0.530)
			()	()	()
Follow-up	L : M	0.024; (0.011–0.317)	0.022; (0.012–0.317)	0.025; (0.011–0.042)	0.022; (0.010–0.072)
	% FES	0.044; (0.00–0.878)	0.040; (0.00–0.259)	0.047; (0.00–0.878)	0.045; (0.010–0.530)

Data is expressed as median and range.
% FES, percentage fractional excretion of sucrose; L : M, lactulose-to-mannitol ratio.
Significantly different from control (, Mann-Whitney test or Wilcoxon Signed Rank Test).